Home › Funds › BRADLEY FOSTER & SARGENT INC/CT › RGEN

BRADLEY FOSTER & SARGENT INC/CT position in RGEN

REPLIGEN CORP · Health Care

BRADLEY FOSTER & SARGENT INC/CT reported holding 198,876 shares of RGEN (REPLIGEN CORP) in its Q3 2026 13F filing — a position valued at US$38.2M, representing 0.55% of its reported portfolio and ranking #47 among its reported holdings. BRADLEY FOSTER & SARGENT INC/CT has disclosed RGEN holdings in 6 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)198.88K sh
Reported value held$38.23M
Portfolio Weight0.55%
First reportedQ4 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How BRADLEY FOSTER & SARGENT INC/CT's RGEN position evolved

BRADLEY FOSTER & SARGENT INC/CT first disclosed a stake in RGEN in Q4 2023 at 5,718 shares (US$1.0M). The position peaked in Q3 2026 at 198,876 shares, worth US$38.2M. Across 6 filings, BRADLEY FOSTER & SARGENT INC/CT increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 198,876 shares valued at US$38.2M — an increase of 3,441 shares quarter over quarter.. Notable position changes include a 45% increase in Q3 2024 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 5.72K $1.03M New
Q1 2024 6.01K $1.11M Add
Q2 2024 5.94K $748.29K Reduce
Q3 2024 8.58K $1.28M Add
Q2 2026 195.44K $26.67M New
Q3 2026 198.88K $38.23M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 35 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has BRADLEY FOSTER & SARGENT INC/CT held RGEN?

BRADLEY FOSTER & SARGENT INC/CT has disclosed RGEN holdings in 6 of the last 12 reported quarters, going back to Q4 2023.

What is BRADLEY FOSTER & SARGENT INC/CT's current position in RGEN?

As of Q3 2026, BRADLEY FOSTER & SARGENT INC/CT holds 198.88K shares of RGEN (REPLIGEN CORP), valued at $38.23M, representing 0.55% of its reported portfolio and ranking #47.

Has BRADLEY FOSTER & SARGENT INC/CT been buying or selling RGEN?

In the latest 13F filing (Q3 2026), BRADLEY FOSTER & SARGENT INC/CT increased its position in RGEN. The position peaked in Q3 2026 at 198.88K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.